- Home
- QSI vs CERS Comparison
QSI vs CERS Comparison
Compare QSI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- CERS
- Stock Information
- Founded
- QSI 2013
- CERS 1991
- Country
- QSI United States
- CERS United States
- Employees
- QSI N/A
- CERS N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- CERS EDP Services
- Sector
- QSI Health Care
- CERS Technology
- Exchange
- QSI Nasdaq
- CERS Nasdaq
- Market Cap
- QSI 226.8M
- CERS 255.0M
- IPO Year
- QSI N/A
- CERS 1997
- Fundamental
- Price
- QSI $1.53
- CERS $1.30
- Analyst Decision
- QSI Strong Buy
- CERS Strong Buy
- Analyst Count
- QSI 3
- CERS 2
- Target Price
- QSI $2.38
- CERS $3.50
- AVG Volume (30 Days)
- QSI 6.9M
- CERS 1.1M
- Earning Date
- QSI 11-11-2025
- CERS 10-29-2025
- Dividend Yield
- QSI N/A
- CERS N/A
- EPS Growth
- QSI N/A
- CERS N/A
- EPS
- QSI N/A
- CERS N/A
- Revenue
- QSI $3,412,000.00
- CERS $192,510,000.00
- Revenue This Year
- QSI N/A
- CERS $22.02
- Revenue Next Year
- QSI $219.33
- CERS $9.32
- P/E Ratio
- QSI N/A
- CERS N/A
- Revenue Growth
- QSI 100.47
- CERS 13.25
- 52 Week Low
- QSI $0.61
- CERS $1.12
- 52 Week High
- QSI $5.77
- CERS $2.24
- Technical
- Relative Strength Index (RSI)
- QSI 67.71
- CERS 52.56
- Support Level
- QSI $1.24
- CERS $1.17
- Resistance Level
- QSI $1.16
- CERS $1.27
- Average True Range (ATR)
- QSI 0.10
- CERS 0.06
- MACD
- QSI 0.06
- CERS 0.00
- Stochastic Oscillator
- QSI 81.97
- CERS 72.22
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.